Standout Papers

Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, a... 2009 2026 2014 2020 2.2k
  1. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease (2009)
    Randy L. Buckner, Jorge Sepulcre et al. Journal of Neuroscience
  2. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016)
    Clifford R. Jack, David A. Bennett et al. Neurology
  3. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia (2009)
    Reisa A. Sperling, Peter S. LaViolette et al. Neuron
  4. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET (2014)
    William E. Klunk, Robert A. Koeppe et al. Alzheimer s & Dementia
  5. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials (2014)
    Reisa A. Sperling, Elizabeth C. Mormino et al. Neuron
  6. The A4 Study: Stopping AD Before Symptoms Begin? (2014)
    Reisa A. Sperling, Dorene M. Rentz et al. Science Translational Medicine
  7. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue (2015)
    Marta Marquié, Marc D. Normandin et al. Annals of Neurology
  8. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology (2013)
    Elizabeth M. Bradshaw, Lori B. Chibnik et al. Nature Neuroscience
  9. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals (2020)
    Reisa A. Sperling, Michael Donohue et al. JAMA Neurology
  10. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease (2022)
    Michael S. Rafii, Reisa A. Sperling et al. Alzheimer s & Dementia
  11. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup (2025)
    Gil D. Rabinovici, David S. Knopman et al. Alzheimer s & Dementia

Immediate Impact

11 by Nobel laureates 10 from Science/Nature 126 standout
Sub-graph 1 of 14

Citing Papers

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
2024 Standout
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
99 intermediate papers

Works of Keith A. Johnson being referenced

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
2022 Standout
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
2017
and 65 more

Author Peers

Author Last Decade Papers Cites
Keith A. Johnson 12887 12085 9588 405 25.1k
Giovanni B. Frisoni 12045 10381 10243 531 29.4k
Prashanthi Vemuri 11636 10475 6664 324 21.2k
Joel H. Kramer 11253 7617 9850 464 27.2k
Robert J. Ivnik 19362 12006 9754 209 32.1k
Lars‐Olof Wahlund 9208 8094 5992 437 23.9k
Mony J. de Leon 11476 13296 5986 297 30.0k
Matthew L. Senjem 10301 10297 6733 317 19.8k
Glenn E. Smith 20433 11954 10532 348 35.6k
Andrew J. Saykin 12161 7067 9166 733 33.4k
Victor L. Villemagne 11120 14026 5274 499 25.2k

All Works

Loading papers...

Rankless by CCL
2026